https://doi.org/10.4049/jimmunol.144.9.3473
C
Craig Okada
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
131
Papers
3.3K
Citations
23
h-index
33
i10-index
Craig Okada is an academic researcher. The author has contributed to research in topics: T-cell and Retrovirus Studies & Lymphoma Diagnosis and Treatment & CAR-T cell therapy research. The author has an h-index of 23, co-authored 112 publications.
ORCID: 0009-0000-7061-0873Papers by this author
worksCharacterization of a rat monoclonal antibody specific for a determinant encoded by the V <i>beta</i> 7 gene segment. Depletion of V <i>beta</i> 7+ T cells in mice with Mls-1a haplotype.
1990 · The Journal of Immunology · 121 citations
TCR vaccines for active immunotherapy of T cell malignancies
1997 · The Journal of Immunology · 37 citations
https://doi.org/10.4049/jimmunol.159.11.5516
TCR Vaccines Against T Cell Lymphoma: QS-21 and IL-12 Adjuvants Induce a Protective CD8+ T Cell Response
1999 · The Journal of Immunology · 36 citations
https://doi.org/10.4049/jimmunol.162.4.2251
Phase 1b Open-Label Study of Loncastuximab Tesirine in Combination With Other Anticancer Agents in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)00813-9
Supplementary Figure S5 from Patient Specific Targeting of the T-cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27031756
Supplementary Figure S3 from Patient Specific Targeting of the T-cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27031762
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat